Savara Inc. (SVRA)
NASDAQ: SVRA · Real-Time Price · USD
5.43
+0.16 (3.04%)
At close: Mar 9, 2026, 4:00 PM EDT
5.43
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:10 PM EDT
Savara Market Cap
Savara has a market cap or net worth of $1.34 billion as of March 9, 2026. Its market cap has increased by 190.60% in one year.
Market Cap
1.34B
Enterprise Value
1.25B
1-Year Change
190.60%
Ranking
Category
Stock Price
$5.43
Market Cap Chart
Since April 28, 2017, Savara's market cap has increased from $132.70M to $1.34B, an increase of 911.08%. That is a compound annual growth rate of 29.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.07B | -12.60% |
| Dec 31, 2025 | 1.23B | 132.85% |
| Dec 31, 2024 | 526.90M | -17.17% |
| Dec 29, 2023 | 636.10M | 259.79% |
| Dec 30, 2022 | 176.80M | 25.21% |
| Dec 31, 2021 | 141.20M | 126.65% |
| Dec 31, 2020 | 62.30M | -66.25% |
| Dec 31, 2019 | 184.60M | -30.58% |
| Dec 31, 2018 | 265.90M | -41.25% |
| Dec 29, 2017 | 452.60M | 241.07% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Monte Rosa Therapeutics | 1.40B |
| Zenas BioPharma | 1.38B |
| AtaiBeckley | 1.37B |
| MBX Biosciences | 1.36B |
| Olema Pharmaceuticals | 1.35B |
| Corvus Pharmaceuticals | 1.33B |
| Immatics | 1.33B |
| Septerna | 1.32B |